GENEVA, 15 July 2025–Lenacapavir–a long-acting, six-monthly injectable antiretroviral medicine manufactured by Gilead Sciences–is now recommended by the World Health Organization as an additional HIV ...

In January the Government of Fiji declared an HIV outbreak in response to the sharp increase in new diagnoses. Although its HIV Surge Strategy seeks to rapidly expand HIV testing and treatment, most ...

Borey and Sophia are among the first clients in Cambodia to begin long-acting injectable Cabotegravir (CAB-LA), a PrEP ...

A historic funding crisis is threatening to unravel decades of progress unless countries can make radical shifts to HIV programming and funding. The report highlights the impact that the sudden, large ...

GENEVA, 25 June 2025 — UNAIDS and Flanders have strengthened their joint efforts to combat the AIDS pandemic in Africa by ...

Secretaría de ONUSIDA 20, Avenue Appia CH-1211 Ginebra 27 Suiza Teléfono: +41 22 791 36 66 Fax: +41 22 791 4187 Si tiene una consulta específica, por favor escriba a la dirección correspondiente: ...

UNAIDS emphasizes that every dollar invested in the HIV response not only saves lives but strengthens health systems and promotes broader development goals. Since the start of the epidemic, 26.9 ...

The 2024 global AIDS report The Urgency of Now: AIDS at a Crossroads, released 22 July 2024, is available here. This report makes clear that there is a path to end AIDS. Taking that path will help ...

GENEVA, 4 July 2025— It is with profound sadness that UNAIDS learns of the passing of the former Deputy President of the ...

Global HIV statistics 39.9 million [36.1 million–44.6 million] people globally were living with HIV in 2023. 1.3 million [1 million–1.7 million] people became newly infected with HIV in 2023. 630 000 ...

Draft Agenda of the 54th PCB pre-meetings (June 19-21, 2024) ...

Documents 2024 global AIDS report — The Urgency of Now: AIDS at a Crossroads 22 July 2024 ...